| • | Record H1 revenues exceed full-year 2024 levels; Q2 cash burn[1] at ~$7.3M; reiterating 2025 revenue guidance; raising NRE bookings targets   | 
| • | Development agreement with Top 5 passenger OEM reinforces Innoviz’s position as a preferred technology partner for global OEMs | 
| • | Supporting increasing demand from new and existing customers; shipped first units from Fabrinet’s high-volume production line  | 

| • | SODW with Top 5 Automotive OEM – signed a Statement of
                Development Work (SODW) agreement with a Top 5 passenger automotive OEM. | 
| • | First units shipping from Fabrinet – to support our customers
                across L3, L4, and non-automotive applications, we have begun shipping units from Fabrinet’s high-volume production line. | 
| • | Launched InnovizSMART – announced the launch of InnovizSMART,
                which brings auto-grade LiDAR to industrial applications such as Security, Mobility, Aerial, Robotics, and Traffic Management. | 
| • | Announced key collaborations with Cogniteam, Sparsh CCTV, CronAI and
                  integration with NVIDIA Jetson Orin platform – shortly after unveiling InnovizSMART, Innoviz announced collaborations with multiple companies to develop a variety of solutions for deployment in areas such as safety, security, and
                others.  | 
| • | Revenues of $50-$60 million, more than 2x 2024 levels; | 
| • | 1-3 new program wins | 
| • | The company is raising its 2025 NRE bookings target to $30-$60 million from $20-$50 million. Year to date, Innoviz has booked over $20 million in NREs.  | 
| INNOVIZ TECHNOLOGIES LTD. AND ITS SUBSIDIARIES CONSOLIDATED STATEMENTS OF OPERATIONS | 
| U.S. dollars in thousands (except share and per share data)  (Unaudited) | 
| Six Months Ended June 30, | Three Months Ended June 30, | |||||||||||||||
|  2025 |  2024 |  2025 |  2024 | |||||||||||||
| Revenues | $ | 27,137 | $ | 13,721 | $ | 9,747 | $ | 6,664 | ||||||||
| Cost of revenues | (18,595 | ) | (15,255 | ) | (8,187 | ) | (6,901 | ) | ||||||||
| Gross profit (loss) | 8,542 | (1,534 | ) | 1,560 | (237 | ) | ||||||||||
| Operating expenses: | ||||||||||||||||
| Research and development | 27,982 | 40,606 | 13,152 | 16,761 | ||||||||||||
| Sales and marketing | 2,891 | 4,116 | 1,170 | 1,716 | ||||||||||||
| General and administrative | 8,676 | 10,233 | 4,221 | 4,789 | ||||||||||||
| Total operating
                expenses | 39,549 | 54,955 | 18,543 | 23,266 | ||||||||||||
| Operating loss | (31,007 | ) | (56,489 | ) | (16,983 | ) | (23,503 | ) | ||||||||
| Financial income (expense), net | (29 | ) | 5,261 | (1,445 | ) | 2,360 | ||||||||||
| Loss before taxes on income | (31,036 | ) | (51,228 | ) | (18,428 | ) | (21,143 | ) | ||||||||
| Taxes on income | (85 | ) | (77 | ) | (51 | ) | (24 | ) | ||||||||
| Net loss | $ | (31,121 | ) | $ | (51,305 | ) | $ | (18,479 | ) | $ | (21,167 | ) | ||||
| Basic and diluted net loss per ordinary share | $ | (0.16 | ) | $ | (0.31 | ) | $ | (0.09 | ) | $ | (0.13 | ) | ||||
| Weighted average number of ordinary shares used in computing basic and diluted net loss per ordinary share | 192,642,299 | 166,095,197 | 200,079,493 | 166,530,895 | ||||||||||||
| INNOVIZ TECHNOLOGIES LTD. AND ITS SUBSIDIARIES CONSOLIDATED BALANCE SHEETS | 
| U.S.
                  dollars in thousands  (Unaudited) | 
|  June 30, | December 31, | |||||||
|  2025 |  2024 | |||||||
| ASSETS | ||||||||
|  CURRENT ASSETS: | ||||||||
| Cash and cash equivalents | $ | 13,535 | $ | 25,365 | ||||
| Short-term restricted cash | 16 | 16 | ||||||
| Bank deposits | 56,574 | 30,628 | ||||||
| Marketable securities | 9,270 | 11,955 | ||||||
| Trade receivables, net | 11,623 | 6,043 | ||||||
| Inventory | 3,201 | 1,905 | ||||||
| Prepaid expenses and other current assets | 6,678 | 6,707 | ||||||
|  Total current assets | 100,897 | 82,619 | ||||||
|  LONG-TERM ASSETS: | ||||||||
| Restricted deposits | 2,897 | 2,725 | ||||||
| Property and equipment, net | 20,752 | 23,432 | ||||||
| Operating lease right-of-use assets, net | 26,469 | 23,194 | ||||||
| Other long-term assets | 90 | 79 | ||||||
|  Total long-term assets | 50,208 | 49,430 | ||||||
|  Total assets | $ | 151,105 | $ | 132,049 | ||||
|  LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||
| CURRENT LIABILITIES: | ||||||||
| Trade payables | $ | 3,346 | $ | 8,813 | ||||
| Deferred revenues | 3,449 | 274 | ||||||
| Employees and payroll accruals | 9,498 | 8,722 | ||||||
| Accrued expenses and other current liabilities | 6,376 | 5,631 | ||||||
| Operating lease liabilities | 5,635 | 4,330 | ||||||
|  Total current liabilities | 28,304 | 27,770 | ||||||
|  LONG-TERM LIABILITIES: | ||||||||
| Operating lease liabilities | 29,625 | 25,264 | ||||||
| Warrants liability | 56 | 86 | ||||||
|  Total long-term liabilities | 29,681 | 25,350 | ||||||
|  SHAREHOLDERS’ EQUITY: | ||||||||
| Ordinary Shares of no-par value | - | - | ||||||
| Additional paid-in capital | 854,286 | 808,974 | ||||||
| Accumulated deficit | (761,166 | ) | (730,045 | ) | ||||
|  Total shareholders’ equity | 93,120 | 78,929 | ||||||
|  Total liabilities and shareholders’ equity | $ | 151,105 | $ | 132,049 | ||||
| INNOVIZ TECHNOLOGIES LTD. AND ITS SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS | 
| U.S. dollars in thousands (Unaudited) | 
| Six Months Ended June 30, | Three Months Ended June 30, | |||||||||||||||
|  2025 |  2024 |  2025 |  2024 | |||||||||||||
| Cash flows from operating activities: | ||||||||||||||||
| Net loss | $ | (31,121 | ) | $ | (51,305 | ) | $ | (18,479 | ) | $ | (21,167 | ) | ||||
| Adjustments required to reconcile net loss to net cash used in operating activities: | ||||||||||||||||
| Depreciation and amortization | 2,715 | 4,036 | 1,338 | 1,541 | ||||||||||||
| Remeasurement of warrants liability | (30 | ) | (149 | ) | 18 | (63 | ) | |||||||||
| Change in accrued interest on bank deposits | (654 | ) | (465 | ) | (317 | ) | 322 | |||||||||
| Change in marketable securities | (91 | ) | (259 | ) | (29 | ) | (101 | ) | ||||||||
| Share-based compensation  | 7,907 | 11,145 | 3,153 | 4,635 | ||||||||||||
| Foreign exchange loss (gain), net | (1,283 | ) | 124 | (1,437 | ) | 170 | ||||||||||
| Change in prepaid expenses and other assets | (131 | ) | 3,153 | (2,260 | ) | 983 | ||||||||||
| Change in trade receivables, net  | (5,580 | ) | 1,977 | 6,038 | (5,081 | ) | ||||||||||
| Change in inventory | 383 | 115 | 182 | 259 | ||||||||||||
| Change in operating lease assets and liabilities, net | 2,391 | (1,327 | ) | 3,103 | (747 | ) | ||||||||||
| Change in trade payables | (4,564 | ) | (2,247 | ) | (987 | ) | (180 | ) | ||||||||
| Change in accrued expenses and other liabilities | 1,049 | (1,187 | ) | 526 | (352 | ) | ||||||||||
| Change in employees and payroll accruals | 776 | 248 | 622 | (858 | ) | |||||||||||
| Change in deferred revenues | 3,175 | (6,487 | ) | 2,231 | (120 | ) | ||||||||||
| Net cash used in operating activities | (25,058 | ) | (42,628 | ) | (6,298 | ) | (20,759 | ) | ||||||||
| Cash flows from investing activities: | ||||||||||||||||
|     Purchase of property and equipment | (2,924 | ) | (2,029 | ) | (1,009 | ) | (880 | ) | ||||||||
|     Proceeds from sales of property and equipment | 3 | - | 3 | - | ||||||||||||
| Investment in bank deposits | (58,700 | ) | (15,500 | ) | (14,400 | ) | (1,500 | ) | ||||||||
| Withdrawal of bank deposits | 33,450 | 56,000 | 20,950 | 31,000 | ||||||||||||
| Investment in restricted deposits | - | (67 | ) | - | - | |||||||||||
| Investment in marketable securities | (22,931 | ) | (14,795 | ) | (8,039 | ) | (13,857 | ) | ||||||||
| Proceeds from sales and maturities of marketable securities | 25,707 | 16,694 | 7,970 | 15,799 | ||||||||||||
| Net cash provided by (used in) investing activities | (25,395 | ) | 40,303 | 5,475 | 30,562 | |||||||||||
| Cash flows from financing activities: | ||||||||||||||||
|     Issuance of ordinary shares and warrants, net of issuance cost | 37,289 | - | (307 | ) | - | |||||||||||
| Proceeds from exercise of options | 265 | 111 | 123 | 69 | ||||||||||||
| Net cash provided by (used in) financing activities | 37,554 | 111 | (184 | ) | 69 | |||||||||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 1,069 | (43 | ) | 1,173 | (117 | ) | ||||||||||
| Increase (decrease) in cash, cash equivalents and restricted cash | (11,830 | ) | (2,257 | ) | 166 | 9,755 | ||||||||||
| Cash, cash equivalents and restricted cash at the beginning of the period | 25,381 | 26,336 | 13,385 | 14,324 | ||||||||||||
| Cash, cash equivalents and restricted cash at the end of the period | $ | 13,551 | $ | 24,079 | $ | 13,551 | $ | 24,079 | ||||||||